1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Generics in India

Generics in India

  • January 2017
  • -
  • MarketLine
  • -
  • 37 pages

Summary
Generics in India industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in India
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in India
- Leading company profiles reveal details of key generics market players' global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the India generics market with five year forecasts by both value and volume

Synopsis
Essential resource for top-line data and analysis covering the India generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons To Buy
- What was the size of the India generics market by value in 2016?
- What will be the size of the India generics market in 2021?
- What factors are affecting the strength of competition in the India generics market?
- How has the market performed over the last five years?
- How large is India's generics market in relation to its regional counterparts?

Key Findings
For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

The Indian generics market is expected to generate total revenues of $13.3bn in 2016, representing a compound annual growth rate (CAGR) of 11.4% between 2012 and 2016.

Market consumption volume is forecast to increase with a CAGR of 1% between 2012 and 2016, to reach a total of 96.4% of total pharma volume in 2016.

The Indian generics market is one of the largest in the world and the market is set to grow due to an ageing population, increased consumer spending, raising healthcare insurance, and rapid urbanization.

Table Of Contents

Generics in India
Table of Contents
Executive Summary
Market value
Market value forecast
Market volume
Market volume forecast
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market volume
Market Segmentation
Geography segmentation
Market Outlook
Market value forecast
Market volume forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Aurobindo Pharma Limited
Cipla Limited
Lupin Limited
Sun Pharmaceutical Industries Ltd.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

List of Tables
Table 1: India generics market value: $ billion, 2012-16(e)
Table 2: India generics market volume: % of total pharma volume, 2012-16(e)
Table 3: India generics market geography segmentation: $ billion, 2016(e)
Table 4: India generics market value forecast: $ billion, 2016-21
Table 5: India generics market volume forecast: % of total pharma volume, 2016-21
Table 6: Aurobindo Pharma Limited: key facts
Table 7: Aurobindo Pharma Limited: key financials ($)
Table 8: Aurobindo Pharma Limited: key financials (Rs.)
Table 9: Aurobindo Pharma Limited: key financial ratios
Table 10: Cipla Limited: key facts
Table 11: Cipla Limited: key financials ($)
Table 12: Cipla Limited: key financials (Rs.)
Table 13: Cipla Limited: key financial ratios
Table 14: Lupin Limited: key facts
Table 15: Lupin Limited: key financials ($)
Table 16: Lupin Limited: key financials (Rs.)
Table 17: Lupin Limited: key financial ratios
Table 18: Sun Pharmaceutical Industries Ltd.: key facts
Table 19: Sun Pharmaceutical Industries Ltd.: key financials ($)
Table 20: Sun Pharmaceutical Industries Ltd.: key financials (Rs.)
Table 21: Sun Pharmaceutical Industries Ltd.: key financial ratios
Table 22: India size of population (million), 2012-16
Table 23: India gdp (constant 2005 prices, $ billion), 2012-16
Table 24: India gdp (current prices, $ billion), 2012-16
Table 25: India inflation, 2012-16
Table 26: India consumer price index (absolute), 2012-16
Table 27: India exchange rate, 2012-16

List of Figures
Figure 1: India generics market value: $ billion, 2012-16(e)
Figure 2: India generics market volume: % of total pharma volume, 2012-16(e)
Figure 3: India generics market geography segmentation: % share, by value, 2016(e)
Figure 4: India generics market value forecast: $ billion, 2016-21
Figure 5: India generics market volume forecast: % of total pharma volume, 2016-21
Figure 6: Forces driving competition in the generics market in India, 2016
Figure 7: Drivers of buyer power in the generics market in India, 2016
Figure 8: Drivers of supplier power in the generics market in India, 2016
Figure 9: Factors influencing the likelihood of new entrants in the generics market in India, 2016
Figure 10: Factors influencing the threat of substitutes in the generics market in India, 2016
Figure 11: Drivers of degree of rivalry in the generics market in India, 2016
Figure 12: Aurobindo Pharma Limited: revenues and profitability
Figure 13: Aurobindo Pharma Limited: assets and liabilities
Figure 14: Cipla Limited: revenues and profitability
Figure 15: Cipla Limited: assets and liabilities
Figure 16: Lupin Limited: revenues and profitability
Figure 17: Lupin Limited: assets and liabilities
Figure 18: Sun Pharmaceutical Industries Ltd.: revenues and profitability
Figure 19: Sun Pharmaceutical Industries Ltd.: assets and liabilities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Animal Antibiotics and Antimicrobials Market by Product, Mode of Delivery, Animal - Global Forecast to 2021

Animal Antibiotics and Antimicrobials Market by Product, Mode of Delivery, Animal - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global animal antibiotics and antimicrobials market is estimated to grow at a CAGR of 4.6% from 2016 to 2021, to reach USD 4.73 billion by 2021 from USD 3.77 billion in 2016. The growth of this market ...

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance

  • $ 4995
  • Industry report
  • January 2017
  • by GBI Research

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance Summary The antibacterial drug market covers ...

Methicillin-resistant Staphylococcus aureus (MRSA) - Market Insights, Epidemiology and Market Forecast-2023

Methicillin-resistant Staphylococcus aureus (MRSA) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Methicillin-resistant Staphylococcus aureus (MRSA) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the ...

Acetic Acid Markets In China

January 2017 $ 4000

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.